Csaba Tóth1,2,3, Jeannine Meinrath4, Esther Herpel5,6, Jutta Derix7, Jochen Fries4, Reinhard Buettner4, Peter Schirmacher5, Sebastian Heikaus7. 1. Institute of Pathology, University Hospital Cologne, Cologne, Germany. csaba.toth@med.uni-heidelberg.de. 2. Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany. csaba.toth@med.uni-heidelberg.de. 3. Center for Integrated Oncology, CIO Biobank, Cologne, Germany. csaba.toth@med.uni-heidelberg.de. 4. Institute of Pathology, University Hospital Cologne, Cologne, Germany. 5. Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany. 6. National Cancer Institute, Tissue Bank, Heidelberg, Germany. 7. University Hospital Düsseldorf, Düsseldorf, Germany.
Abstract
INTRODUCTION: Apoptotic signaling is one of the most important processes in the measurement of chemotherapeutic effectiveness. In apoptotic machinery, various pathways and proteins are involved (i.e., mismatch repair proteins, p53). One of the regulatory proteins is ARC, which can inhibit not only the extrinsic but also the intrinsic apoptotic signaling. MATERIALS AND METHODS: In this study, we investigated the expression levels of ARC in colorectal liver metastasis and compared them with the expression of mismatch repair proteins and p53. Furthermore, we investigated ARC expression level depending on sex, age, tumor grade, mucin production, tumor size and number of liver metastasis. RESULTS: ARC expression level in colorectal cancer liver metastasis was independent from clinical data (i.e., age, gender, tumor size, tumor number or mucin production) but strongly correlated with MSH2 and MSH6 expression, which further supported the evidence for the regulatory role of MSH2 and MSH6 in apoptosis; i.e., in case of sufficient MSH2 and MSH6 expression, significantly higher ARC level is required to suppress the apoptosis. A regulatory interaction between ARC and p53 has been described, but we found no correlation between p53 expression levels and ARC levels. CONCLUSION: Further studies are needed to define the exact role of ARC in apoptotic signaling and thus its role in chemoresistance and survival of tumor cells.
INTRODUCTION: Apoptotic signaling is one of the most important processes in the measurement of chemotherapeutic effectiveness. In apoptotic machinery, various pathways and proteins are involved (i.e., mismatch repair proteins, p53). One of the regulatory proteins is ARC, which can inhibit not only the extrinsic but also the intrinsic apoptotic signaling. MATERIALS AND METHODS: In this study, we investigated the expression levels of ARC in colorectal liver metastasis and compared them with the expression of mismatch repair proteins and p53. Furthermore, we investigated ARC expression level depending on sex, age, tumor grade, mucin production, tumor size and number of liver metastasis. RESULTS: ARC expression level in colorectal cancer liver metastasis was independent from clinical data (i.e., age, gender, tumor size, tumor number or mucin production) but strongly correlated with MSH2 and MSH6 expression, which further supported the evidence for the regulatory role of MSH2 and MSH6 in apoptosis; i.e., in case of sufficient MSH2 and MSH6 expression, significantly higher ARC level is required to suppress the apoptosis. A regulatory interaction between ARC and p53 has been described, but we found no correlation between p53 expression levels and ARC levels. CONCLUSION: Further studies are needed to define the exact role of ARC in apoptotic signaling and thus its role in chemoresistance and survival of tumor cells.
Authors: A M Valentini; M L Caruso; R Armentano; M Pirrelli; E Rizzi; F Lapenna; L Renna Journal: Anticancer Res Date: 1999 Jul-Aug Impact factor: 2.480
Authors: Jiangwei Li; Ghada S Hassan; Terence M Williams; Carlo Minetti; Richard G Pestell; Herbert B Tanowitz; Philippe G Frank; Federica Sotgia; Michael P Lisanti Journal: Cell Cycle Date: 2005-12-22 Impact factor: 4.534
Authors: Roger S-Y Foo; Young-Jae Nam; Marc Jason Ostreicher; Mark D Metzl; Russell S Whelan; Chang-Fu Peng; Anthony W Ashton; Weimin Fu; Kartik Mani; Suet-Feung Chin; Elena Provenzano; Ian Ellis; Nichola Figg; Sarah Pinder; Martin R Bennett; Carlos Caldas; Richard N Kitsis Journal: Proc Natl Acad Sci U S A Date: 2007-12-17 Impact factor: 11.205
Authors: Bruno Christian Koehler; Anna-Lena Scherr; Stephan Lorenz; Christin Elssner; Nicole Kautz; Stefan Welte; Dirk Jaeger; Toni Urbanik; Henning Schulze-Bergkamen Journal: PLoS One Date: 2014-09-05 Impact factor: 3.240
Authors: Xiong Min; Han Heng; Hua-Long Yu; Mao Dan; Chen Jie; Yun Zeng; He Ning; Zhi-Gang Liu; Zhi-Yong Wang; Wang Lin Journal: Oncol Lett Date: 2017-12-13 Impact factor: 2.967
Authors: Csaba Tóth; Farkas Sükösd; Erzsébet Valicsek; Esther Herpel; Peter Schirmacher; László Tiszlavicz Journal: Oncol Lett Date: 2018-01-09 Impact factor: 2.967
Authors: Csaba Tóth; Farkas Sükösd; Erzsébet Valicsek; Esther Herpel; Peter Schirmacher; Marcus Renner; Christoph Mader; László Tiszlavicz; Jörg Kriegsmann Journal: Int J Mol Med Date: 2017-09-14 Impact factor: 4.101
Authors: Christoph Roser; Csaba Tóth; Marcus Renner; Esther Herpel; Peter Schirmacher Journal: Cell Commun Signal Date: 2021-02-12 Impact factor: 5.712